{"id":1068114,"date":"2021-05-26T01:51:22","date_gmt":"2021-05-26T05:51:22","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/sinovant-sciences-and-nabriva-therapeutics-announce-positive-topline-results-from-phase-3-trial-of-lefamulin-in-chinese-adults-with-community-acquired\/"},"modified":"2024-08-18T11:43:03","modified_gmt":"2024-08-18T15:43:03","slug":"sinovant-sciences-and-nabriva-therapeutics-announce-positive-topline-results-from-phase-3-trial-of-lefamulin-in-chinese-adults-with-community-acquired","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sinovant-sciences-and-nabriva-therapeutics-announce-positive-topline-results-from-phase-3-trial-of-lefamulin-in-chinese-adults-with-community-acquired.php","title":{"rendered":"Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired&#8230;"},"content":{"rendered":"<p><![CDATA[HONG KONG, SHANGHAI, China, SUZHOU, China and DUBLIN, Ireland, May  25, 2021  (GLOBE NEWSWIRE) -- Sinovant Sciences, a Chinese biopharmaceutical company dedicated to conducting innovative biomedical R&D in China, and Nabriva Therapeutics (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced positive topline results from Sinovant\u2019s Phase 3 bridging study of lefamulin in Chinese adults with community acquired bacterial pneumonia (CABP).]]><\/p>\n<p>See the article here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/05\/25\/2235969\/0\/en\/Sinovant-Sciences-and-Nabriva-Therapeutics-Announce-Positive-Topline-Results-from-Phase-3-Trial-of-Lefamulin-in-Chinese-Adults-with-Community-Acquired-Bacterial-Pneumonia-CABP.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired...\">Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the article here: Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sinovant-sciences-and-nabriva-therapeutics-announce-positive-topline-results-from-phase-3-trial-of-lefamulin-in-chinese-adults-with-community-acquired.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068114","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068114"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068114"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068114\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}